References in this report (the "Quarterly Report") to "we," "us" or the "Company" refer to Austerlitz Acquisition Corporation II. References to our "management" or our "management team" refer to our officers and directors, references to the "Sponsor" refer to Austerlitz Acquisition Sponsor, LP I. The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes "forward-looking statements" that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding the Company's financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as "expect," "believe," "anticipate," "intend," "estimate," "seek" and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management's current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and in any of the Company's subsequent SEC filings. The Company's securities filings can be accessed on the EDGAR section of the SEC's website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated on January 5, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate a Business Combination using cash from the proceeds of our IPO and the Private Placement, the proceeds of the sale of our shares in connection with a Business Combination, shares issued to the owners of the target, debt issued to bank or other lenders or the owners of the target, or a combination of the foregoing.



The registration statement for our IPO was declared effective on February 25,
2021. On March 2, 2021, we completed our IPO of 138,000,000 Units sold to the
public, including the issuance of 18,000,000 Units as a result of the
underwriter's exercise in full of its over-allotment option, at the price of
$10.00 per Unit, generating gross proceeds of $1,380,000,000. Each Unit consists
of one Class A ordinary share of the Company and
one-fourth
of one redeemable warrant. Each whole Public Warrant entitles the holder to
purchase one Class A ordinary share at an exercise price of $11.50 per share,
subject to adjustment. Simultaneously with the closing of our IPO, we completed
the sale to Cannae Holdings, LLC of an aggregate of 19,733,333 Private Placement
Warrants at a price of $1.50 per Private Placement Warrant, generating gross
proceeds of approximately $29,600,000. Each Private Placement Warrant is
exercisable for one Class A ordinary share at a price of $11.50 per share,
subject to adjustment. The proceeds from the Private Placement were added to the
net proceeds from the IPO held in the Trust Account.

Following our IPO, the full exercise of the over-allotment option and the Private Placement, a total of $1,380,000,000 was placed in the Trust Account. We incurred $28,359,571 in transaction costs, including $27,600,000 of underwriting fees and $759,571 of other offering costs.

The Company's management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete its initial Business Combination with one or more target businesses that together have a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriting commissions held in the Trust Account) at the time the Company signs a definitive agreement in connection with a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended.


                                       17

--------------------------------------------------------------------------------

Table of Contents

We expect to continue to incur significant costs in the pursuit of our initial Business Combination. We cannot assure you that our plans to complete a Business Combination will be successful.

The

COVID-19


pandemic has caused difficult market and economic conditions globally since its
outbreak in 2020, and the full impact of the
COVID-19
pandemic continues to evolve. The impact of the
COVID-19
outbreak on our results of operations, financial position and cash flows will
depend on future developments, including resurgences and variants of the virus
that causes
COVID-19,
as well as efforts to reduce its spread, such as travel bans and other
restrictions. These developments and the impact of the
COVID-19
outbreak on the financial markets and the overall economy are highly uncertain
and cannot be predicted. If the financial markets and/or the overall economy
continue to be impacted for an extended period, our ability to complete our
initial Business Combination may be materially adversely affected due to
significant governmental measures to contain the
COVID-19
pandemic or treat its impact, including travel restrictions, the shutdown of
businesses and quarantines, among others, which may limit our ability to have
meetings with potential investors or affect the ability of a potential target
company's personnel, vendors and service providers to negotiate and consummate
our initial Business Combination in a timely manner.

Results of Operations



We have neither engaged in any operations nor generated any revenues to date.
Our only activities since inception have been organizational activities, those
necessary to prepare for our IPO and, after completing our IPO, identifying a
target company for a Business Combination. We do not expect to generate any
operating revenues until after completion of a Business Combination. We may
generate
non-operating
income in the form of interest income on marketable securities held in the Trust
Account. We incur expenses as a result of being a public company (for legal,
financial reporting, accounting and auditing compliance), as well as expenses as
we conduct due diligence on prospective Business Combination candidates.
Additionally, we recognize
non-cash
gains and losses related to changes in recurring fair value measurements of our
Warrant liabilities at each reporting period.

For the six months ended June 30, 2022, we had net income of $46,994,189, which
consists of $521,477 in general and administrative expenses, offset by
non-cash
gains of $47,515,666 related to changes in the fair value of the warrants and
forward purchase agreement. For the period from January 5, 2021 (Inception)
through June 30, 2021, we had net income of $13,977,484, which consisted of
$250,144 in general and administrative costs, $5,000 of formation costs,
$3,181,372 related to transaction costs allocated to derivative warrant
liabilities, offset by
non-cash
gains of $17,414,000 related to changes in the fair value of the warrants and
forward purchase agreement,

For the three months ended June 30, 2022, we had net income of $24,229,735,
which consists of $257,931 in general and administrative costs, offset by
non-cash
gains of $24,229,735 related to changes in the fair value of the warrants and
forward purchase agreement. For the three months ended June 30, 2021, we had net
income of $25,124,705, which consisted of $181,294 in general and administrative
expenses and
non-cash
gains of $25,305,999 related to changes in the fair value of the warrants and
forward purchase agreement.

Liquidity and Capital Resources

As of June 30, 2022, we had cash of $955 outside of the Trust Account.

As of June 30, 2022, we had cash of $1,380,000,000 held in the Trust Account. We intend to use substantially all of the funds held in the Trust Account (less taxes paid and deferred underwriting commissions) to complete a Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

In order to fund working capital deficiencies or finance transaction costs in connection with our initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial Business Combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants identical to the Private Placement Warrants, at a price of $1.50 per warrant at the option of the lender.


                                       18

--------------------------------------------------------------------------------

Table of Contents


We currently expect that financial support of our Sponsor will be sufficient to
operate our business through the earlier of a Business Combination or March 2,
2023, the date of our mandatory liquidation should we fail to consummate a
Business Combination. However, if our estimate of the costs of identifying a
target business, undertaking
in-depth
due diligence and negotiating our initial Business Combination are more than the
actual amount necessary to do so, we may have insufficient funds available to
operate our business prior to our initial Business Combination. Moreover, we may
need to obtain additional financing either to complete our initial Business
Combination or because we become obligated to redeem a significant number of our
Public Shares upon consummation of our initial Business Combination, in which
case we may issue additional securities or incur debt in connection with such
Business Combination. Subject to compliance with applicable securities laws, we
would only complete such financing simultaneously with the completion of our
initial Business Combination. If we are unable to complete our initial Business
Combination because we do not have sufficient funds available to us, we will be
forced to cease operations and liquidate the Trust Account. In addition,
following our initial Business Combination, if cash on hand is insufficient, we
may need to obtain additional financing in order to meet our obligations.

For the six months ended June 30, 2022, cash used by operating activities was $258,411. Net income of $46,994,189 was affected by non-cash gains of $48,390,666 related to changes in the fair value of derivative warrant liabilities, loss of $875,000 related to change in fair value of forward purchase asset or liability, and changes in operating assets and liabilities, which used $263,066 of cash from operating activities.


For the period from January 5, 2021 (Inception) through June 30, 2021, cash used
by operating activities $1,092,071. Net income of $13,977,484 was affected by
$3,181,372 in transaction costs allocated to derivative warrant liabilities,
$18,289,000 of
non-cash
gains in the fair value of derivative warrant liabilities, $875,000 related to
loss change in fair value of forward purchase liability, $5,000 related to
formation and operating expenses paid through issuance of Class B and C ordinary
shares, and changes in operating assets and liabilities, which used $841,927 of
cash from operating activities.

The Company had no cash flow from investing or financing activities in the six months ended June 30, 2022.

For the six months ended June 30, 2021, net cash used in investing activities was $1,380,000,000, which consisted of $1,380,000,000 investment of cash into the trust account. Net cash provided by financing activities of $1,381,483,858 was affected by $388,152 of repayment of promissory note - related party, $127,990 of offering costs paid, and offset by $1,352,400,000 of proceeds from sale of Units, net of deferred underwriting discounts paid, and $29,600,000 of proceeds from the sale of Private Placement Warrants.

See discussion under the header "Liquidity and Going Concern Consideration" in Note 1 to our unaudited condensed financial statements included in Item 1 of Part I of this Quarterly Report for discussion of management's consideration of the Company's ability to continue as a going concern.

Off-Balance

Sheet Financing Arrangements



We had no obligations, assets or liabilities, which would be considered
off-balance
sheet arrangements as of June 30, 2022 or December 31, 2021. We do not
participate in transactions that create relationships with unconsolidated
entities or financial partnerships, often referred to as variable interest
entities. We have not entered into any
off-balance
sheet financing arrangements, established any special purpose entities,
guaranteed any debt or commitments of other entities, or purchased any
non-financial
assets.

Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay an affiliate of our sponsor a monthly fee up to $5,000 for office space and administrative support services. We began incurring these fees on March 2, 2021 and will continue to incur these fees monthly until the earlier of the completion a Business Combination and our liquidation.


The Company will provide its shareholders with the opportunity to redeem all or
a portion of their Public Shares upon the completion of a Business Combination
either (i) in connection with a general meeting called to approve the Business
Combination or (ii) by means of a tender offer. The decision as to whether the
Company will seek shareholder approval of a Business Combination or conduct a
tender offer will be made by the Company. The shareholders will be entitled to
redeem their shares for a pro rata portion of the amount held in the Trust
Account (initially $10.00 per share), calculated as of two business days prior
to the completion of a Business Combination, including any pro rata interest
earned on the funds held in the Trust Account and not previously released to the
Company to pay its tax obligations. There will be no redemption rights upon the
completion of a Business Combination with respect to the Company's warrants. The
Class A ordinary shares are recorded at redemption value and classified as
temporary equity, in accordance with Accounting Standards Codification ("ASC")
Topic 480,
Distinguishing Liabilities from Equity
("ASC 480").

                                       19

--------------------------------------------------------------------------------

Table of Contents

Critical Accounting Estimates

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the period reported. Actual results could materially differ from those estimates. We have identified the following critical accounting estimates effecting our financial statements:

Warrant and Forward Purchase Liabilities


The Company accounts for the Warrants and Forward Purchase Agreement ("FPA") as
either equity-classified or liability-classified instruments based on an
assessment of the specific terms of the Warrants and FPA and the applicable
authoritative guidance in ASC 480 and ASC Topic 815,
Derivatives and Hedging
("ASC 815"). The assessment considers whether the Warrants and FPA are
freestanding financial instruments pursuant to ASC 480, meet the definition of a
liability pursuant to ASC 480, and meet all of the requirements for equity
classification under ASC 815, including whether the Warrants and FPA are indexed
to the Company's own ordinary shares and whether the warrant holders could
potentially require "net cash settlement" in a circumstance outside of the
Company's control, among other conditions for equity classification. This
assessment, which requires the use of professional judgment, is conducted at the
time of issuance of the Warrants and execution of the FPA and as of each
subsequent quarterly period end date while the Warrants and FPA are outstanding.
For issued or modified instruments such as warrants and forward purchases of
equity that meet all of the criteria for equity classification, such instruments
are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified instruments that do not
meet all the criteria for equity classification, such instruments are required
to be recorded as liabilities at their initial fair value on the date of
issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of liability-classified instruments are recognized as a
non-cash
gain or loss on the unaudited condensed statements of operations.

The Company accounts for the Warrants and FPA in accordance with ASC 815-40 under which the Warrants and FPA do not meet the criteria for equity classification and must be recorded as assets or liabilities. The assets and liabilities for the Warrants and FPA are included in Warrant liability and Forward purchase agreement asset or liability, respectively, on the balance sheet as of June 30, 2022 and December 31, 2021.

See Note 8 to our unaudited condensed financial statements included in Item 1 of Part I of this Quarterly Report for further discussion of the pertinent items of the Warrants and Note 9 for further discussion of the methodology used to determine the fair value of the Company's liabilities for the Warrants and FPA.

Class A Ordinary Shares Subject to Possible Redemption

We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders' equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, the Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders' equity section of our condensed balance sheets.

Net Income (Loss) per Ordinary Share



The Company has three classes of shares, one for each of its Class A, Class B,
and Class C ordinary shares. Income and losses are shared pro rata between the
three classes of shares. Net income per ordinary share is computed by dividing
net income by the weighted average number of ordinary shares outstanding during
the period. We apply the
two-class
method in calculating earnings per share. Refer to Note 2 to our unaudited
condensed financial statements included in Item 1 of Part I of this Quarterly
Report for further discussion of the calculation of our net income per share.

Recently Issued Accounting Pronouncements

Refer to Note 2 to our unaudited condensed financial statements included in Item 8 of this Quarterly Report for discussion of management's consideration of recently issued accounting pronouncements.

© Edgar Online, source Glimpses